The role of radiation therapy in the management of non-small cell lung cancer.

M. Machtay, J. S. Friedberg

Research output: Contribution to journalReview articlepeer-review

4 Scopus citations


Lung cancer remains the number one cancer killer for both men and women in the United States. Most patients with lung cancer will receive radiotherapy as part of their treatment. For non-small cell lung cancer, this treatment will be administered as either neoadjuvant, adjuvant, definitive, or palliative therapy. Occasionally the distinction between these classifications may be unclear or may change in the course of the treatment. The use of thoracic radiotherapy as part of the treatment regimen and the goal of the therapy depends not just on tumor-related factors such as stage, but also on patient-related factors such as pulmonary reserve and performance status. This article describes the use of radiotherapy in each of the previously listed capacities and details the potential benefits and complication of this treatment modality for non-small cell lung cancer.

Original languageEnglish
Pages (from-to)80-89
Number of pages10
JournalSeminars in Thoracic and Cardiovascular Surgery
Issue number1
StatePublished - Jan 1997


  • Carcinoma, Non-Small-Cell Lung/radiotherapy
  • Dose-Response Relationship, Radiation
  • Female
  • Humans
  • Lung Neoplasms/radiotherapy
  • Lung/radiation effects
  • Male
  • Palliative Care
  • Radiation Injuries/therapy
  • Radiotherapy Dosage
  • Radiotherapy, Adjuvant


Dive into the research topics of 'The role of radiation therapy in the management of non-small cell lung cancer.'. Together they form a unique fingerprint.

Cite this